Study: Nalls, 2014

Population Ethnicity Diagnosis Source # Cases (% women) # Controls (% women) AAO (sd) AAO range AAE (sd) AAE range Ctrl age (sd) Ctrl age range # Polymorphisms
USA (CHARGE-FHS) C UKPDSBB PO 60 (42%) 3889 (55%) 76 (11) - - - 64 (12) - 9,223

Polymorphisms in this population [-]

Polymorphism Location (hg19) Gene Allele contrast Ethnicity # Studies # Samples 1000G CEU 1000G CHB+JPT Meta OR (95%CI) I2 (95%CI) Meta P-value
rs2668624 chr17:44352872 ARL17B G vs. A All: C 3 8,333 0.217 (G) - 0.64 (0.54-0.76) 59 (0-88) 2.98e-07
rs2668625 chr17:44352970 ARL17B A vs. C All: C 3 8,333 0.208 (A) - 0.59 (0.48-0.72) 60 (0-89) 3.32e-07
rs2732704 chr17:44353114 ARL17B C vs. T All: C 3 8,333 0.208 (C) - 0.60 (0.49-0.73) 61 (0-89) 3.38e-07
rs2668626 chr17:44353175 ARL17B C vs. T All: C 3 8,333 0.208 (C) - 0.59 (0.49-0.73) 61 (0-89) 3.43e-07
rs2458217 chr17:44353206 ARL17B C vs. T All: C 3 8,333 0.208 (C) - 0.60 (0.50-0.74) 64 (0-90) 4.40e-07
rs36050210 chr17:44353414 ARL17B A vs. G All: C 3 8,333 - - 1.55 (1.31-1.84) 67 (0-91) 5.98e-07
rs55964807 chr17:44353505 ARL17B C vs. T All: C 3 8,333 - - 1.65 (1.35-2.01) 67 (0-91) 5.97e-07
rs2668627 chr17:44353693 ARL17B C vs. T All: C 3 8,333 0.217 (C) - 0.65 (0.55-0.77) 67 (0-91) 5.66e-07
rs2732702 chr17:44353728 ARL17B G vs. T All: C 3 8,333 0.217 (G) - 0.66 (0.56-0.78) 68 (0-91) 6.16e-07
rs2668628 chr17:44353885 ARL17B A vs. G All: C 3 8,333 0.217 (A) - 0.65 (0.55-0.77) 68 (0-91) 6.33e-07
rs2732701 chr17:44354103 ARL17B G vs. A All: C 3 8,333 0.217 (G) - 0.66 (0.56-0.78) 68 (0-91) 6.18e-07
rs2668629 chr17:44354231 ARL17B A vs. G All: C 3 8,333 - - 1.51 (1.28-1.77) 70 (0-91) 7.53e-07
rs2668630 chr17:44354587 ARL17B G vs. A All: C 3 8,333 0.208 (G) - 0.61 (0.50-0.74) 70 (0-91) 7.59e-07
rs2950690 chr17:44354908 ARL17B C vs. T All: C 3 8,333 - - 1.71 (1.38-2.11) 70 (0-91) 7.95e-07
rs2942178 chr17:44354980 ARL17B A vs. C All: C 3 8,333 0.208 (A) - 0.60 (0.49-0.74) 70 (0-91) 8.14e-07
rs2696535 chr17:44355130 ARL17B A vs. G All: C 3 8,333 - - 1.59 (1.32-1.91) 70 (0-91) 8.10e-07
rs2696534 chr17:44355162 ARL17B A vs. G All: C 3 8,333 - - 1.54 (1.30-1.83) 71 (1-91) 8.00e-07
rs2696533 chr17:44355343 ARL17B C vs. T All: C 3 8,333 0.192 (C) - 0.67 (0.57-0.79) 73 (8-92) 1.20e-06
rs2696532 chr17:44355602 ARL17B G vs. A All: C 3 8,333 0.217 (G) - 0.67 (0.56-0.79) 74 (12-92) 1.37e-06
rs2552462 (chr17:44708736) chr17:44491152 intergenic A vs. T All: C 10 31,764 - - 1.55 (1.39-1.73) 35 (0-69) 2.78e-15
rs199460 chr17:44764775 NSF A vs. C All: C 15 108,990 - - 1.34 (1.26-1.43) 35 (0-65) 7.10e-21
rs62074079 (chr17:44764981) chr17:44547284 LRRC37A2 [-41593bp] C vs. G All: C 15 108,990 - - 1.46 (1.37-1.56) 11 (0-48) 1.61e-33
rs143572569 chr17:44776843 NSF T vs. C All: C 13 42,826 - - 1.62 (1.47-1.78) 10 (0-49) 7.38e-23
rs200403 chr17:44781143 NSF A vs. C All: C 15 108,990 - - 1.27 (1.21-1.32) 26 (0-60) 2.49e-27
rs116988420 chr17:44782279 NSF C vs. G All: C 15 108,990 - - 1.46 (1.37-1.55) 6 (0-57) 1.40e-34
rs199451 chr17:44801784 NSF A vs. G All: C 15 108,990 0.208 (A) - 0.78 (0.75-0.81) 10 (0-48) 5.80e-34
rs199447 chr17:44812188 NSF T vs. C All: C 15 108,990 0.208 (T) - 0.78 (0.75-0.81) 12 (0-50) 5.75e-34
rs9912530 chr17:44836302 NSF [+1472bp] T vs. C All: C 15 108,990 0.275 (T) 0.275 (C) 0.81 (0.78-0.84) 23 (0-58) 1.42e-26
rs199530 chr17:44836653 NSF [+1823bp] G vs. A All: C 15 108,990 0.242 (G) 0.275 (A) 0.80 (0.77-0.83) 26 (0-60) 3.86e-29
rs199528 chr17:44843136 WNT3 T vs. C All: C 15 108,990 0.192 (T) - 0.77 (0.74-0.81) 19 (0-56) 2.37e-34
rs199526 chr17:44847707 WNT3 C vs. G All: C 15 108,990 0.192 (C) 0.292 (G) 0.78 (0.75-0.82) 20 (0-56) 9.25e-32
rs199525 chr17:44847834 WNT3 G vs. T All: C 15 108,990 0.2 (G) - 0.77 (0.74-0.81) 19 (0-56) 2.78e-34
rs199518 chr17:44854580 WNT3 A vs. C All: C 15 108,990 0.217 (A) 0.325 (C) 0.79 (0.76-0.82) 24 (0-59) 1.74e-28
rs199517 chr17:44854587 WNT3 A vs. G All: C 15 108,990 0.233 (A) 0.283 (G) 0.79 (0.76-0.82) 23 (0-59) 1.42e-28
rs199510 chr17:44857929 WNT3 C vs. A All: C 15 108,990 - - 1.30 (1.24-1.35) 24 (0-59) 1.69e-32
rs199508 chr17:44858838 WNT3 C vs. G All: C 15 108,990 0.225 (C) 0.425 (G) 0.79 (0.76-0.83) 27 (0-61) 1.31e-29
rs199498 chr17:44865603 WNT3 C vs. T All: C 15 108,990 0.192 (C) 0.442 (T) 0.77 (0.74-0.81) 6 (0-56) 3.49e-29
rs199497 chr17:44866602 WNT3 C vs. T All: C 13 97,715 0.2 (C) - 0.84 (0.80-0.88) 43 (0-70) 2.27e-11
rs1563304 chr17:44874453 WNT3 T vs. C All: C 14 103,235 0.2 (T) 0.0 (T) 0.88 (0.85-0.92) 45 (0-70) 2.36e-08
rs3851781 chr17:44891301 WNT3 T vs. C All: C 15 108,990 0.492 (T) 0.267 (C) 1.09 (1.05-1.12) 0 (0-45) 5.07e-07
rs72836354 chr17:44899464 WNT3 A vs. G All: C 15 108,990 0.475 (A) 0.233 (G) 1.09 (1.05-1.12) 0 (0-22) 3.00e-07
rs3851782 chr17:44901654 WNT3 A vs. G All: C 15 108,990 0.45 (A) - 1.07 (1.04-1.11) 0 (0-27) 1.24e-05
rs34724124 chr17:44902516 WNT3 A vs. G All: C 15 108,990 0.475 (A) 0.242 (G) 1.09 (1.05-1.12) 0 (0-27) 6.88e-07
rs8069437 chr17:44906949 WNT3 T vs. C All: C 15 108,990 0.167 (T) 0.0 (T) 0.91 (0.88-0.95) 15 (0-53) 6.00e-06
rs2165846 chr17:44941366 WNT9B G vs. A All: C 15 108,990 0.417 (G) 0.1 (A) 1.09 (1.05-1.12) 0 (0-43) 4.27e-07
rs6504591 chr17:44944828 WNT9B G vs. T All: C 15 108,990 0.467 (G) 0.1 (G) 0.93 (0.90-0.96) 29 (0-62) 1.92e-05
rs60372268 chr17:44947756 WNT9B G vs. A All: C 15 108,990 0.258 (G) 0.483 (G) 1.14 (1.10-1.19) 0 (0-51) 9.61e-10
rs61619946 chr17:44947757 WNT9B C vs. T All: C 15 108,990 0.267 (C) - 1.14 (1.10-1.19) 0 (0-51) 9.58e-10
rs57986961 chr17:44947821 WNT9B A vs. G All: C 15 108,990 0.317 (A) 0.483 (A) 1.12 (1.08-1.17) 0 (0-52) 2.35e-09
rs11654422 chr17:44950237 WNT9B A vs. G All: C 15 108,990 0.275 (A) 0.425 (A) 1.13 (1.08-1.17) 0 (0-38) 4.48e-08